Orexo AB (publ)
ORXOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | 0.12 | 0.17 | -0.03 |
| FCF Yield | -8.99% | -27.63% | -29.70% | -22.57% |
| EV / EBITDA | 58.96 | -32.50 | -13.74 | -9.16 |
| Quality | ||||
| ROIC | -37.54% | -18.40% | -28.80% | -24.61% |
| Gross Margin | 87.78% | 86.08% | 83.57% | 86.04% |
| Cash Conversion Ratio | 0.23 | 0.74 | 0.85 | 1.07 |
| Growth | ||||
| Revenue 3-Year CAGR | -1.87% | 4.18% | -2.01% | -12.55% |
| Free Cash Flow Growth | 67.34% | 36.90% | 35.95% | -62.98% |
| Safety | ||||
| Net Debt / EBITDA | 27.13 | -13.76 | -5.51 | -0.33 |
| Interest Coverage | -2.34 | -2.66 | -7.71 | -7.98 |
| Efficiency | ||||
| Inventory Turnover | 1.20 | 2.10 | 1.38 | 0.85 |
| Cash Conversion Cycle | 242.57 | 148.84 | 116.63 | 353.14 |